Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT
Clinical trial NCT04137653 · RECRUITING
Trial details
- NCT number
- NCT04137653
- Sponsor
- Shengjing Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-19
- Primary completion
- 2025-11-30
- Enrollment
- 1498
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.